Beckman Coulter Life Sciences signed a definitive agreement to acquire m2p-labs, a privately held, microbioreactor manufacturer based in Baesweiler, Germany. m2p-labs is best known for its transformative BioLector plate-based microbioreactors, which support automated solutions for screening ... more
Beckman Coulter Life Sciences acquires Dublin biotech start-up
Beckman Coulter Life Sciences announces it has acquired ValitaCell Ltd. Headquartered in Dublin, Ireland, ValitaCell creates analytical technologies and products for the biopharmaceutical industry with the goal of reducing new therapeutics' cost and time to market. Compared to other industry IgG quantification assays, the ValitaTiter product outperforms in terms of speed and ease of use, and offers numerous advantages over other long and tedious techniques, like ELISA and HPLC.
“ValitaCell has a proven record for delivering innovative products and we are excited to build upon our successful partnership with Beckman Coulter Life Sciences,” said Dr. Jerry Clifford, Co-Founder and CEO of ValitaCell. “We never take for granted what our advancements can do for patients while also reducing manual workflow burdens on laboratory staff. Together with Beckman Coulter Life Sciences, we will advance our shared ambition to accelerate and enable the sustainable manufacture of innovative biological medicines to bring them to market faster.”
ValitaCell technologies are patented in key international markets and the company has been honored with several awards, including the Irish Pharmaceutical Awards’ Pharma Start-up of the Year in 2017 and InterTrade Ireland’s Seedcorn awards. It also was recognized as one of the most successful Irish companies in Horizon 2020.
“Throughout our trusted partnership with ValitaCell, we have long admired their innovative offerings and industry expertise,” said Jason Lanie, Vice President and General Manager of the Biotechnology Business Unit at Beckman Coulter Life Sciences. “Their leading portfolio of products, including ValitaTiter, Quantum, CellAi, and ChemStress Clone Robustness complement Beckman Coulter Life Sciences’ existing and future product portfolio, and are designed with the same goal of providing faster cellular analysis while decreasing the risk of errors. We are excited to welcome their team and look forward to growing the Ireland Innovation and Development Centers for Biologics to help meet evolving customer needs.”
ValitaCell locations in Dublin and Galway, Ireland will remain operational and are anticipated to grow in response to business needs.
- Beckman Coulter
Beckman Coulter Life Sciences announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California. Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with une ... more
Beckman Coulter Life Sciences announced that their Aquios CL flow cytometer has been accepted by the World Health Organization (WHO) Prequalification of In Vitro Diagnostics Programme. It can now be used specifically for the immunologic assessment of patients having, or suspected of having, ... more
- 1Miniaturized infrared detectors
- 2A new tool for estimating people’s total exposure to potentially harmful chemicals is developed by Mount Sinai researchers
- 3Can smartphones predict mortality risk?
- 4Fighting tumours with magnetic bacteria
- 5Advances in spectroscopy
- 6New collaboration between Shimadzu and the University Medical Center Göttingen
- 7New Molecular Microscopy Uncovers how Breast Cancer Spreads
- 8Imaging cells: New method enables clear, precise look inside
- 9Smarter sensor sniffs out target gases
- 10Pharmacoscopy: Next-Generation Microscopy
- Beckman Coulter Life Sciences acquires Dublin biotech start-up
- Scientists create luminescent gels with multitude of applications from counterfeiting to bio-sensing
- Scientists create 3D-printed, microscopic gas sensors - painters’ pallets without even a hint of pigment
- Major breakthrough identifies new mechanism for the development of schizophrenia
- Detecting Mercury with Gold